Cargando…
BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway
Researchers have shown that bone mesenchymal stem cells (BMSCs) can alleviate the progression of liver cirrhosis; however, it is unclear how exactly BMSCs function to cure liver disease. In this study, we used bioinformatics methods to assess differentially expressed genes (DEGs) in liver cirrhosis...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618771/ https://www.ncbi.nlm.nih.gov/pubmed/37920508 http://dx.doi.org/10.1016/j.heliyon.2023.e21010 |
_version_ | 1785129848713248768 |
---|---|
author | Zhangdi, Hanjing Geng, Xinyu Li, Ning Xu, Ruiling Hu, Ying Liu, Jingyang Zhang, Xu Qi, Jihan Tian, Yingying Qiu, Jiawei Huang, Shiling Cang, Xueyu Jin, Shizhu |
author_facet | Zhangdi, Hanjing Geng, Xinyu Li, Ning Xu, Ruiling Hu, Ying Liu, Jingyang Zhang, Xu Qi, Jihan Tian, Yingying Qiu, Jiawei Huang, Shiling Cang, Xueyu Jin, Shizhu |
author_sort | Zhangdi, Hanjing |
collection | PubMed |
description | Researchers have shown that bone mesenchymal stem cells (BMSCs) can alleviate the progression of liver cirrhosis; however, it is unclear how exactly BMSCs function to cure liver disease. In this study, we used bioinformatics methods to assess differentially expressed genes (DEGs) in liver cirrhosis and found a significantly upregulated gene, Fstl1, in liver cirrhosis. In vivo and in vitro experiments showed that compared with those in the disease model group, the mRNA, and protein expression levels of Fstl1 were significantly reduced after BMSCs treatment, and the β-Catenin protein level was also significantly reduced after BMSCs treatment. Subsequently, we downregulated Fstl1 in activated hepatic stellate cells (HSCs) and found that Wnt and β-Catenin protein expression levels also decreased. Finally, we found that in BMSCs-treated activated HSCs, overexpression of Fstl1 reversed the inhibitory effect of BMSCs on the Wnt/β-Catenin signaling pathway to a certain extent. In summary, our results show that BMSCs can inhibit Wnt/β-Catenin signaling pathway activation by downregulating the protein expression level of Fstl1, thus alleviating cirrhosis. Therefore, targeted regulation of Fstl1 may provide a new therapeutic strategy for the progression of liver cirrhosis. |
format | Online Article Text |
id | pubmed-10618771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-106187712023-11-02 BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway Zhangdi, Hanjing Geng, Xinyu Li, Ning Xu, Ruiling Hu, Ying Liu, Jingyang Zhang, Xu Qi, Jihan Tian, Yingying Qiu, Jiawei Huang, Shiling Cang, Xueyu Jin, Shizhu Heliyon Research Article Researchers have shown that bone mesenchymal stem cells (BMSCs) can alleviate the progression of liver cirrhosis; however, it is unclear how exactly BMSCs function to cure liver disease. In this study, we used bioinformatics methods to assess differentially expressed genes (DEGs) in liver cirrhosis and found a significantly upregulated gene, Fstl1, in liver cirrhosis. In vivo and in vitro experiments showed that compared with those in the disease model group, the mRNA, and protein expression levels of Fstl1 were significantly reduced after BMSCs treatment, and the β-Catenin protein level was also significantly reduced after BMSCs treatment. Subsequently, we downregulated Fstl1 in activated hepatic stellate cells (HSCs) and found that Wnt and β-Catenin protein expression levels also decreased. Finally, we found that in BMSCs-treated activated HSCs, overexpression of Fstl1 reversed the inhibitory effect of BMSCs on the Wnt/β-Catenin signaling pathway to a certain extent. In summary, our results show that BMSCs can inhibit Wnt/β-Catenin signaling pathway activation by downregulating the protein expression level of Fstl1, thus alleviating cirrhosis. Therefore, targeted regulation of Fstl1 may provide a new therapeutic strategy for the progression of liver cirrhosis. Elsevier 2023-10-20 /pmc/articles/PMC10618771/ /pubmed/37920508 http://dx.doi.org/10.1016/j.heliyon.2023.e21010 Text en © 2023 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Zhangdi, Hanjing Geng, Xinyu Li, Ning Xu, Ruiling Hu, Ying Liu, Jingyang Zhang, Xu Qi, Jihan Tian, Yingying Qiu, Jiawei Huang, Shiling Cang, Xueyu Jin, Shizhu BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway |
title | BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway |
title_full | BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway |
title_fullStr | BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway |
title_full_unstemmed | BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway |
title_short | BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway |
title_sort | bmscs alleviate liver cirrhosis by regulating fstl1/wnt/β-catenin signaling pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618771/ https://www.ncbi.nlm.nih.gov/pubmed/37920508 http://dx.doi.org/10.1016/j.heliyon.2023.e21010 |
work_keys_str_mv | AT zhangdihanjing bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT gengxinyu bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT lining bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT xuruiling bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT huying bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT liujingyang bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT zhangxu bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT qijihan bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT tianyingying bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT qiujiawei bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT huangshiling bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT cangxueyu bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway AT jinshizhu bmscsalleviatelivercirrhosisbyregulatingfstl1wntbcateninsignalingpathway |